Vyne – Page 21 – VYNE Therapeutics

SEC Filing: Form 8-K

March, 12 2020

Current report

Post date March 12, 2020

SEC Filing: Form 8-K

March, 10 2020

Current report

Post date March 10, 2020

SEC Filing: Form S-8

March, 09 2020

Securities to be offered to employees in employee benefit plans

Post date March 9, 2020

SEC Filing: Form 10-K

March, 03 2020

Annual report [Section 13 and 15(d), not S-K Item 405]

Post date March 3, 2020

SEC Filing: Form 8-K

March, 03 2020

Current report

Post date March 3, 2020

SEC Filing: Form SC 13G/A

February, 14 2020

Statement of acquisition of beneficial ownership by individuals – amendment

Post date February 14, 2020

Nothing left to load.